Algorae Pharmaceuticals Limited Stock
Stocks
1AI
AU0000296022
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0120 AUD | -.--% |
|
-7.69% | -14.29% |
| Market Cap | 20.26M 14.22M 12.36M 11.5M 10.56M 19.95M 1.36B 136M 53.22M 676M 53.4M 52.23M 2.27B | P/E 2024 |
-7.7x | P/E 2025 | -10x |
|---|---|---|---|---|---|
| Enterprise Value | 17.94M 12.59M 10.94M 10.19M 9.35M 17.66M 1.2B 120M 47.13M 598M 47.29M 46.25M 2.01B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
80.31% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -7.69% | ||
| 1 month | -7.69% | ||
| 3 months | -14.29% | ||
| 6 months | -42.86% | ||
| Current year | -14.29% |
| 1 week | 0.01 |  | 0.01 |
| 1 month | 0.01 | | 0.01 |
| Current year | 0.01 | | 0.02 |
| 1 year | 0 | | 0.02 |
| 3 years | 0 | | 0.02 |
| 5 years | 0 | | 0.02 |
| 10 years | 0 | | 0.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Mckenna
CTO | Chief Tech/Sci/R&D Officer | - | 2023-06-18 |
Catherine Earlie
SEC | Corporate Secretary | - | 2026-06-30 |
| Corporate Secretary | - | 2026-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
David Hainsworth
CHM | Chairman | 52 | 2023-01-04 |
David Gulland
BRD | Director/Board Member | - | 2026-03-09 |
Troy Valentine
BRD | Director/Board Member | 52 | 2026-07-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -7.69% | +100.00% | -29.41% | 17.06M | |
| +2.35% | +2.74% | +38.10% | +71.29% | 56.54B | |
| -0.21% | -7.38% | +27.52% | +61.15% | 53.6B | |
| -2.44% | +1.40% | -15.61% | -15.45% | 22.91B | |
| -2.85% | -7.78% | -9.28% | +345.55% | 21.37B | |
| +2.49% | -0.92% | +23.57% | -13.14% | 20.27B | |
| +0.79% | -1.06% | +33.99% | -31.95% | 17.56B | |
| +0.58% | -5.88% | +19.40% | +527.50% | 14.75B | |
| +3.41% | -6.61% | +162.81% | +278.22% | 13.53B | |
| -5.25% | -4.23% | +42.32% | +170.15% | 13.33B | |
| Average | -0.11% | -4.18% | +42.28% | +136.39% | 23.39B | |
| Weighted average by Cap. | +0.23% | -2.96% | +30.80% | +116.83% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -2.1M -1.47M -1.28M -1.19M -1.09M -2.06M -140M -14.03M -5.51M -69.91M -5.52M -5.4M -234M | -803K -564K -490K -456K -419K -791K -53.81M -5.38M -2.11M -26.79M -2.12M -2.07M -89.82M |
| Net Debt | -3.11M -2.18M -1.9M -1.77M -1.62M -3.06M -208M -20.81M -8.17M -104M -8.19M -8.01M -348M | -2.32M -1.63M -1.42M -1.32M -1.21M -2.28M -155M -15.53M -6.09M -77.37M -6.11M -5.98M -259M |
Employees
48
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | A$0.0120 | -.--% | 976,027 |
| 26-07-30 | A$0.0120 | -7.69% | 1,645,519 |
| 26-07-29 | A$0.0130 | +8.33% | 127 |
| 26-07-28 | A$0.0120 | -7.69% | 670,972 |
| 26-07-27 | A$0.0130 | -.--% | 370,670 |
- Stock Market
- Stocks
- 1AI Stock
Select your edition
All financial news and data tailored to specific country editions
